Poor response to hepatitis C treatment in elderly patients
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3
Abstract
[b]Introduction[/b]. Treatment of genotype 1 chronic hepatitis C in elderly patients has been associated with low rates of a sustained virological response (SVR), but the reasons are unclear. Objective. To determine the SVR rate in patients ≥ 60 years with genotype 1 chronic hepatitis C treated with Peg-IFN and ribavirin, and to identify risk factors related to treatment response in this specific group of patients. [b]Material and methods[/b]. Patients were divided into < 60 years (non-elderly) and ≥60 years (elderly) and were compared regarding clinical, laboratory and histological characteristics and response to treatment. [b]Results[/b]. A total of 231 patients were included in the study. The elderly group (n=89) presented a predominance of women, more advanced hepatic disease, higher glucose, cholesterol and LDL levels, lower hemoglobin levels, and a larger proportion of overweight subjects. The SVR rate was lower (25% vs 46%) and anemia, ribavirin dose reduction and use of filgrastim and erythropoietin were more frequent in elderly patients. Negative predictive factors of SVR in the whole group (n = 231) were glucose ≥ 100 mg/dL and age ≥ 60 years. In the elderly group, only pretreatment variables (lower serum glucose and higher hemoglobin levels) were associated with SVR. [b]Conclusion[/b]. The SVR rate was low in elderly patients. However, this poor response was notdue to poor tolerance, but mainly to pretreatment conditions. Among elderly patients, the best candidates for hepatitis C treatment are those with elevated pretreatment hemoglobin levels and adequate glycemic control.
Authors and Affiliations
Ivonete Silva, Roberto Filho, Ana Feldner, Iandra Zaros, Antonio Silva, Maria Ferraz
Keywords
Related Articles
- EP ID EP78278
- DOI -
- Views 124
- Downloads 0
Annual Meeting of the Mexican Association pf Hepatology
Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination
Approximately 10% of individuals do not respond to hepatitis B virus (HBV) vaccination, i.e. non-responders (NRs). We aimed to investigate the association of interleukin (IL)-4 and IL-12B gene polymorphisms with respons...
title
abstrakt<br/><br/>
Biliverdin and Heme Oxygenase Antiviral Activity Against Hepatitis C Virus
Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients
Background and aims. Autoimmune hepatitis (AIH) is a chronic inflammatory condition of the liver in which the immunologicalmechanisms involved in tissue destruction and/or repair are still unclear. Different pro-inflamm...